ReviewMolecules (Basel, Switzerland)2026
Hybrid Mucointeractive Delivery Systems-Alternative Approaches to Mucosal Delivery.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mucosa can be found in the eyes, oral cavity, bladder, vagina, airways, and gastrointestinal tract. It is an attractive route of administration for systemic or topical delivery of therapeutics. However, the mucus layer acts as a protective barrier, limiting the amount of biomolecules that reach the underlying epithelium. Mucoadhesion, mucodiffusion, and mucolysis are well-established mucointeractive strategies that can improve therapeutic outcomes, but due to their individual limitations, the resulting delivery is often still unsatisfactory. In recent years, drug delivery systems have emerged that combine multiple mucointeractive strategies, which we define here as hybrid mucointeractive delivery systems. This work aims to provide a general overview of such drug delivery systems, which include particle-releasing macrostructures such as gels, foams, films, and fibers, as well as systems such as zeta potential-changing particles and self-emulsifying drug delivery systems. Their potential, possible future, and limitations are discussed as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.